巴西粘膜利什曼病治疗直接成本估算数据集

数据集获取（Figshare）

• 源站标题：Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
• DOI：10.6084/m9.figshare.14277325.v1
• 发布日期：2021-03-24
• 文件数：4 个
• 文件总体积：30.72 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Estimating_direct_costs_of_the_treatment_for_mucosal_leishmaniasis_in_Brazil/14277325

命令行下载

curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/27090286"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/27090289"
curl -L -o "Table_3.xls" "https://ndownloader.figshare.com/files/27090292"
curl -L -o "Table_4.xls" "https://ndownloader.figshare.com/files/27090295"

文件清单

• Table_1.xls（5.63 KB）
• Table_2.xls（9.73 KB）
• Table_3.xls（9.73 KB）
• Table_4.xls（5.63 KB）

文件总体积 30.72 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Abstract INTRODUCTION: The objective of this study was to estimate the direct medical costs of the treatment for mucosal leishmaniasis (ML) using three therapeutic approaches in the Brazilian context. METHODS: We performed this economic assessment from the perspective of the Brazilian public healthcare system. The following therapeutic approaches were evaluated: meglumine antimoniate, liposomal amphotericin B, and miltefosine. Direct medical costs were estimated considering four treatment components: a) drug, b) combined medical products, c) procedures, and d) complementary tests. RESULTS: Treatment with meglumine antimoniate had the lowest average cost per patient (US$ 167.66), followed by miltefosine (US$ 259.92) in the outpatient treatment regimen. The average cost of treatment with liposomal amphotericin B was US$ 715.35 both in inpatient regimen. In all estimates, the drugs accounted for more than 60% of the total cost for each treatment approach. CONCLUSIONS: These results demonstrate the marked differences in costs between the therapeutic alternatives for ML. In addition to efficacy rates and costs related to adverse events, our data have the potential to support a complete cost-effectiveness study in the future. Complete analyses comparing costs and benefits for interventions will assist health managers in choosing drugs for ML treatment in Brazil as well as in establishing effective public health policies.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.14277325.v1（source: https://scielo.figshare.com/articles/dataset/Estimating_direct_costs_of_the_treatment_for_mucosal_leishmaniasis_in_Brazil/14277325）。